Krane Funds Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,326
Closed -$496K 94
2024
Q1
$496K Sell
2,326
-4
-0.2% -$840 0.02% 49
2023
Q4
$491K Sell
2,330
-317
-12% -$67.6K 0.02% 61
2023
Q3
$530K Sell
2,647
-185
-7% -$36.8K 0.02% 48
2023
Q2
$525K Buy
+2,832
New +$523K 0.03% 54
2023
Q1
Sell
-3,037
Closed -$511K 110
2022
Q4
$511K Buy
+3,037
New +$528K 0.02% 67
2022
Q2
Sell
-1,588
Closed -$378K 299
2022
Q1
$378K Sell
1,588
-10
-0.6% -$2.35K 0.02% 260
2021
Q4
$365K Buy
+1,598
New +$352K 0.01% 259
2020
Q3
Sell
-2,130
Closed -$346K 238
2020
Q2
$346K Buy
+2,130
New +$382K 0.02% 222

Other funds holding CME

Krane Funds Advisors's CME Position: Q2 2024 in Review

Krane Funds Advisors sold out of CME Group (CME) in Q2 2024, closing a stake of 2,326 shares — an estimated $496K sold.

Krane Funds Advisors first reported a position in CME in Q2 2020 and held it in 8 quarters. The position peaked at $530K in Q3 2023. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Krane Funds Advisors reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Krane Funds Advisors sold 2,326 CME Group shares in Q2 2024, an estimated $496K.
  • Krane Funds Advisors first reported a position in CME Group in Q2 2020 and held it in 8 quarters.
  • Krane Funds Advisors's CME Group position peaked at $530K in Q3 2023.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Krane Funds Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.